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We do not believe that disease is caused by one streptococcal
superantigen, and it is quite possible that the 2 cases analyzed by
Michie represent true expansion ofV(32T cells; however, it would
be helpful to increase the number of cases analyzed and to deter-
mine the changes in the entire V(3 repertoire of these patients.
It should be emphasized that the majority of studies that have
investigated the in vivo effects of superantigens have documented
the deletion of superantigen-specific V(3bearing cells following a
brief window of V(3 expansion [3-6]. In some cases, expansion
was not detected and only V(3 depletion was seen [6]. I believe
that this is related to the type of superantigen and the magnitude
of the inflammatory cytokine response elicited in the host during
the infection. Thus, it should not be surprising to observe V(3
depletion in STSS, which is consistent with the severe inflamma-
tory response in these patients. However, as we indicated in [2],
we cannot rule out that earlier expansion of these V(3-bearing T
cells may have taken place.
As to the method used to analyze the T cell receptor (TCR)
repertoire, we agree that this method is quite difficult and if not
done properly can generate misleading results. However, we have
used this method for > 5 years and optimized the conditions to
the point that the technique is quite reliable and reproducible [7].
We [8, 9] and others [10] have compared the results with those
obtained by flow cytometry and found very good correlation. Fur-
thermore, because the number of anti-V(3 antibodies is limited, it
is not possible to analyze the entire repertoire by flow cytometry
and consequently it is not possible to determine changes in other
V(3 elements. We agree with Michie that multiple methods should
be used to analyze the TCR repertoire; however, because of the
limited amount of blood that can be obtained from patients, this
option is not always available. In addition, we fully agree that
analysis of the repertoire in CD4 versus CD8 cells and in activated
versus naive T cells is important, and we are developing methods
to allow us to address this point in STSS patients.
Finally, although Michie reported the repertoire of only 2 STSS
cases, his finding of a possible V(32 expansion and our finding of
V(3I, V(35.1, and V(3l2 depletion underscores the importance of
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To the Editor-Weiss et al. [I] compared the effect of different
prophylactic regimens against Plasmodium falciparum malaria in
9- to l4-year-old children in Saradidi in western Kenya. They
considered two outcome measures, the cumulative incidence of
parasitemia and the cumulative incidence of "symptomatic fal-
ciparum malaria."
A diagnosis of symptomatic falciparum malaria in that study
required the presence of malaria parasites in a thick smear and
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analyzing the TCR repertoire of STSS patients in the context of
the superantigen profile of their respective isolates. Such studies
are currently underway in our laboratory and should help us better
understand the mechanism of pathogenesis of severe streptococcal
infections.
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at least one of the following: history of fever or chills, axillary
temperature>37.5°C, headache, musculoskeletal aches, or abdom-
inal pains.
The authors acknowledge that ~20% of all blood smears were
positive for P. falciparum, and hence that other illnesses would
occur along with an incidentally positive smear leading to an over-
diagnosis of malaria. In fact, it is well known that in children of
the age range studied, clinical malaria attacks in areas of high
endemicity are infrequent [2]. It is possible to estimate the propor-
tion of clinical episodes attributable to malaria by considering the
excess risk among the infected persons. When we did an analysis
with data from areas of malaria endemicity comparable to Saradidi,
we found that only a small proportion of the clinical episodes were
attributable to malaria in children> 10 years old [3, 4].
It seems likely that the vast majority of the clinical episodes
reported by Weiss et al. are not in fact of malarial etiology. The
authors are to be congratulated on their well-designed study and
important contribution to the study of malarial prophylaxis in East
Africa; however, it is doubtful that their analyses give a valid
comparison of the clinical efficacy of the different regimens. It
